AR204816A1 - Procedimiento para preparar una prostaglandina - Google Patents

Procedimiento para preparar una prostaglandina

Info

Publication number
AR204816A1
AR204816A1 AR250900A AR25090073A AR204816A1 AR 204816 A1 AR204816 A1 AR 204816A1 AR 250900 A AR250900 A AR 250900A AR 25090073 A AR25090073 A AR 25090073A AR 204816 A1 AR204816 A1 AR 204816A1
Authority
AR
Argentina
Prior art keywords
prostaglandin
prepare
procedure
Prior art date
Application number
AR250900A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR204816A1 publication Critical patent/AR204816A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
AR250900A 1972-11-08 1973-01-01 Procedimiento para preparar una prostaglandina AR204816A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
AR204816A1 true AR204816A1 (es) 1976-03-05

Family

ID=23178143

Family Applications (2)

Application Number Title Priority Date Filing Date
AR250900A AR204816A1 (es) 1972-11-08 1973-01-01 Procedimiento para preparar una prostaglandina
AR254983A AR202311A1 (es) 1972-11-08 1974-07-31 Ciclopentano intermediario

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR254983A AR202311A1 (es) 1972-11-08 1974-07-31 Ciclopentano intermediario

Country Status (24)

Country Link
JP (1) JPS5644068B2 (hu)
AR (2) AR204816A1 (hu)
AT (1) AT347607B (hu)
BE (1) BE807047A (hu)
CA (1) CA1027559A (hu)
CH (1) CH601222A5 (hu)
CS (1) CS188175B2 (hu)
DD (2) DD111370A5 (hu)
DE (2) DE2365999A1 (hu)
ES (2) ES420326A1 (hu)
FI (1) FI58116C (hu)
FR (2) FR2205339B1 (hu)
GB (1) GB1456511A (hu)
HU (2) HU171818B (hu)
IE (1) IE39686B1 (hu)
IL (1) IL43553A (hu)
IN (1) IN139905B (hu)
NL (1) NL7315240A (hu)
NO (2) NO145437C (hu)
PH (2) PH15504A (hu)
SE (2) SE420198B (hu)
SU (2) SU538659A3 (hu)
YU (2) YU287973A (hu)
ZA (1) ZA738593B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361381A1 (fr) * 1972-07-13 1978-03-10 Pfizer Ethers tetrahydropyranyliques, utiles comme intermediaires de synthese de prostaglandines
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (de) * 1976-08-27 1978-03-09 Pfizer C tief 1 -p-biphenylester von omega-pentanorprostaglandinen
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
NO146280C (no) 1982-09-01
JPS49100060A (hu) 1974-09-20
JPS5644068B2 (hu) 1981-10-16
NO145437C (no) 1982-03-24
AR202311A1 (es) 1975-05-30
SE420198B (sv) 1981-09-21
CH601222A5 (hu) 1978-06-30
HU171945B (hu) 1978-04-28
DE2355042A1 (de) 1974-05-22
PH13794A (en) 1980-10-01
NL7315240A (hu) 1974-05-10
FR2275452A1 (fr) 1976-01-16
FR2275452B1 (hu) 1977-12-16
CS188175B2 (en) 1979-02-28
HU171818B (hu) 1978-03-28
IN139905B (hu) 1976-08-14
IE39686L (en) 1974-05-08
NO146280B (no) 1982-05-24
FR2205339A1 (hu) 1974-05-31
CA1027559A (en) 1978-03-07
DD111370A5 (hu) 1975-02-12
ATA937173A (de) 1978-05-15
IE39686B1 (en) 1978-12-06
AT347607B (de) 1979-01-10
DE2365999A1 (de) 1977-05-12
PH15504A (en) 1983-02-03
FI58116B (fi) 1980-08-29
NO743588L (no) 1974-05-09
FI58116C (fi) 1980-12-10
IL43553A0 (en) 1974-03-14
SE7704369L (sv) 1977-04-15
FR2205339B1 (hu) 1980-01-04
YU287973A (en) 1982-02-25
IL43553A (en) 1979-10-31
SU538659A3 (ru) 1976-12-05
DD113211A5 (hu) 1975-05-20
ZA738593B (en) 1974-10-30
NO145437B (no) 1981-12-14
SU1021340A3 (ru) 1983-05-30
GB1456511A (en) 1976-11-24
ES434687A1 (es) 1976-12-16
ES420326A1 (es) 1976-03-16
YU264480A (en) 1983-04-27
BE807047A (fr) 1974-05-08
AU6222573A (en) 1975-05-08

Similar Documents

Publication Publication Date Title
AR206393A1 (es) Elementos para conformar una unidad de tabica-sofito-canalon
AR202939A1 (es) Procedimiento para producir fortimicina a
AR203373A1 (es) Procedimiento para preparar 4-amino-quinazolinas
AR211871A1 (es) Procedimiento para obtener derivados de 7beta-amino-3-cefem-3-ol-4-carboxilicos
AR199711A1 (es) Procedimiento para obtener penicilinas novedosas
BR7302706D0 (pt) Uma maquina para desintegrar
AR215640A1 (es) Procedimiento para preparar un derivado 2-acilamino-oxazolico
AR195663A1 (es) Procedimiento para preparar un dentifrico estable
AR209733A1 (es) Mejoras en una cinta de soporte para cierres corredizos
AR214271A1 (es) Procedimiento para alcohilar hidrocarburos
AR200521A1 (es) Procedimiento para producir 6-deoxitetraciclinas
AR200244A1 (es) Un procedimiento para producir azaspiranos
AR207946A1 (es) Procedimiento para preparar 2-amino-metilenindanona
AR209064A1 (es) Procedimiento para preparar nuevos analogos de prostaglandinas
AR211914A1 (es) Procedimiento de preparacion de una nueva(diciclopropilmetil-2-aminotizolina
AR210453A1 (es) Procedimiento para la preparacion de una 6-alfa-dioxitetraciclina
AR206887A1 (es) Procedimiento para preparar nuevos d-2-halo-6-metil-8-cianometilergolinas
AR195442A1 (es) Un procedimiento para separar lactamas
AR200736A1 (es) Procedimiento para producir nuevos compuestos de piperacinil quinazolinadionas
AR204816A1 (es) Procedimiento para preparar una prostaglandina
AR203722A1 (es) Procedimiento para producir una desacetoxicefalosporina y compuesto intermediario para su produccion
AR201924A1 (es) Procedimiento para la produccion de una u-n-nse-alfa sustituida-omega-aminoalcanoile-neamina /-ribostamicina
AR198543A1 (es) Metodo para preparar 2-sustituida-4-(r) - hidroxi - 2-ciclopententen-1-ona
AR207232A1 (es) Procedimiento para preparar un derivado benzoxazolico
AR197057A1 (es) Procedimiento para preparar 1- arilidenamino-4- (2 - oxo -3 - fenil - 3 - benzofuril) piperacinas